Is NEOS A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Neos Therapeutics Inc. (NEOS)
This company is not actively trading or the ticker does belong to another company in our database now.
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 3. | Stonepine Capital Timothy P. Lynch | 0 | $0 | 0% | |
| 4. | Deerfield Management James E. Flynn | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.16 | 5,000 | $10,819.50 | 42,460 | 2018-12-12 | Filing | |
| $2.11 | 17,097 | $36,119.12 | 24,500 | 2018-12-06 | Filing | |
| $2.04 | 7,403 | $15,119.89 | 7,403 | 2018-12-04 | Filing | |
| $2.30 | 43,478 | $99,999.40 | 423,366 | 2018-11-08 | Filing | |
| $6.54 | 1,500 | $9,810.00 | 1,500 | 2016-08-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.88 | 213 | $2,105.31 | 39,998 | 2016-04-20 | Filing | |
| $10.03 | 182 | $1,825.28 | 40,211 | 2016-04-19 | Filing | |
| $10.10 | 114 | $1,151.35 | 40,393 | 2016-04-18 | Filing | |
| $9.88 | 8,327 | $82,304.90 | 1,559,995 | 2016-04-20 | Filing | |
| $10.03 | 7,097 | $71,175.81 | 1,568,322 | 2016-04-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Here is What Hedge Funds Think About Neos Therapeutics Inc (NEOS)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Do Hedge Funds Love Neos Therapeutics Inc (NEOS)?
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump.
13G Filing: James E. Flynn and Neos Therapeutics Inc (NEOS)
Neos Therapeutics Inc (NASDAQ:NEOS): James E. Flynn's Deerfield Management filed an amended 13D.
You can check out Deerfield Management's latest holdings and filings here.
Why PayPal (PYPL), Facebook (FB), and 3 Other Stocks Are Skyrocketing Today
Major U.S stock indexes are up slightly on Thursday as the markets continue to recuperate from their terrible start to 2016.
How Did Michael Castor's Picks Play Out in Q4?
Chances are that some people have not heard of Michael Castor or his healthcare-focused hedge fund Sio Capital. Mr.
Neos Therapeutics Inc (NEOS): Are Hedge Funds Right About This Stock?
Is Neos Therapeutics Inc (NASDAQ:NEOS) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors...
Healthcare-Focused Investor Believes These Three Cheap Stocks are Poised to Explode
September was one of the worst periods for healthcare stocks and the returns of healthcare-focused investors suffered a lot amid an 11% drop in the NASDAQ Biotech ETF (IBB) and a 16% decline in the S...
Scary Day For Investors Of These 4 Sliding Stocks
Shares of Neos Therapeutics Inc (NASDAQ:NEOS), Rambus Inc. (NASDAQ:RMBS), Zogenix, Inc. (NASDAQ:ZGNX), and International Business Machines Corp.
James Flynn's Deerfield Management Ups Its Stake In Neos Therapeutics Inc. (NEOS)
James E. Flynn’s Deerfield Management disclosed that it has upped its position in Neos Therapeutics Inc.
Hedge Fund Resource Center